Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive
Norwood, MA 02062
April 30, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Corbus Pharmaceuticals Holdings, Inc. (the “Company”) |
Registration Statement on Form S-3, as amended (File No. 333-237588)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:15 p.m., Eastern Time, on May 1, 2020, or as soon as practicable thereafter.
Please call Michael J. Lerner of Lowenstein Sandler LLP at (973) 597-6394 to confirm the effectiveness of the Registration Statement or with any questions.
[Signature page follows.]
U.S. Securities and Exchange Commission
April 30, 2020
Page 2
| Very truly yours, | ||
| CORBUS PHARMACEUTICALS | ||
| HOLDINGS, INC. | ||
| By: | /s/ Sean Moran | |
| Name: | Sean Moran | |
| Title: | Chief Financial Officer | |
| -2- |
